Patents by Inventor Jeffrey C. Wang

Jeffrey C. Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200323786
    Abstract: Growth factors are of great potential in regenerative medicine. However, their clinical applications are largely limited in by short in vivo half-lives and a narrow therapeutic window. Thus, a robust controlled release system remains an unmet medical need for growth-factor-based therapies. A nanoscale controlled release system (degradable protein nanocapsule) is provided via in-situ polymerization on growth factor. The release rate can be finely tuned by engineering the surface polymer composition. Improved therapeutic outcomes are achieved with the growth factor nanocapsules, as illustrated in spinal cord fusion mediated by bone morphogenetic protein-2 (BMP-2) nanocapsules.
    Type: Application
    Filed: May 24, 2017
    Publication date: October 15, 2020
    Applicants: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE UNIVERSITY OF SOUTHERN CALIFORNIA, TIANJIN UNIVERSITY
    Inventors: Yunfeng Lu, Jeffrey C. Wang, Haijun Tian, Juanjuan Du, Jing Wen, Yang Liu, Xubo Yuan
  • Publication number: 20190254720
    Abstract: Laminoplasty plates are engageable to at least one portion of a divided lamina to maintain a desired spacing relative to the spinal canal. The laminoplasty plates include a spacer portion having a first end and a second end that spans a gap formed by at least one of a divided lamina portion. The laminoplasty plates can include a lamina engagement portion at one end for engagement with the divided lamina portion.
    Type: Application
    Filed: April 30, 2019
    Publication date: August 22, 2019
    Applicant: WARSAW ORTHOPEDIC, INC.
    Inventors: William B. Null, Robert W. Weakley, Gregory C. Marik, John G. Heller, Jeffrey C. Wang
  • Patent number: 10314621
    Abstract: Laminoplasty plates are engageable to at least one portion of a divided lamina to maintain a desired spacing relative to the spinal canal. The laminoplasty plates include a spacer portion having a first end and a second end that spans a gap formed by at least one of a divided lamina portion. The laminoplasty plates can include a lamina engagement portion at one end for engagement with the divided lamina portion.
    Type: Grant
    Filed: January 24, 2014
    Date of Patent: June 11, 2019
    Assignee: Warsaw Orthopedic, Inc.
    Inventors: William B. Null, Robert W. Weakley, Gregory C. Marik, John G. Heller, Jeffrey C. Wang
  • Patent number: 9855368
    Abstract: A cyclized peptide designated BMP Binding Peptide (BBP) is a synthetic peptide that avidly binds rhBMP-2, as do endogenous forms of BBP, and sequence conservation between species results in a variety of useful BBP compositions. BBP increases the over-all osteogenic activity of rhBMP-2, increases the rate at which rhBMP-2 induces bone formation, and BBP induces calcification alone. Compositions and substrates including BBP, and methods of using BBP are useful in therapeutic, diagnostic and clinical applications requiring calcification and osteogenesis.
    Type: Grant
    Filed: March 6, 2015
    Date of Patent: January 2, 2018
    Assignees: The Regents of the University of California, Department of Veterans Affairs
    Inventors: Samuel S. Murray, Elsa J. Murray, Jeffrey C. Wang, Keyvan Behnam
  • Patent number: 9610320
    Abstract: The present invention relates to the clinical application of BBP, alone or in combination with other growth factors, for use in bone healing applications, such as spinal surgery. Additional applications include use in orthopedic implantable prostheses and implantation into other surgical sites (e.g., surgical reconstruction, regional osteopenia, etc.) where bone is desired.
    Type: Grant
    Filed: June 5, 2015
    Date of Patent: April 4, 2017
    Assignees: REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
    Inventors: Samuel S. Murray, Elsa J. Brochmann-Murray, Keyvan Behnam, Jeffrey C. Wang
  • Publication number: 20150305914
    Abstract: A multi-layer cast for immobilizing a body member of a patient includes a hydrophobic sleeve having a shape configured to be applied over the body member and substantially conform to the shape of the body member, and a moldable layer configured to be positioned around said sleeve and hardened to conform to the shape of said body member adjacent said sleeve is presented. The hydrophobic sleeve includes fibers configured to wick moisture outward away from the body member, and the moldable layer includes a network of pores that extend through the moldable layer such that the pores are configured to contact the hydrophobic sleeve to promote flow of moisture from the hydrophobic sleeve outward through the moldable layer. An external removable wrap may also be detachably disposed around the moldable layer for additional support and moisture wicking.
    Type: Application
    Filed: April 30, 2015
    Publication date: October 29, 2015
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Benjamin M. Wu, Jeffrey C. Wang, Emily W. Loughran
  • Publication number: 20150265673
    Abstract: The present invention relates to the clinical application of BBP, alone or in combination with other growth factors, for use in bone healing applications, such as spinal surgery. Additional applications include use in orthopedic implantable prostheses and implantation into other surgical sites (e.g., surgical reconstruction, regional osteopenia, etc.) where bone is desired.
    Type: Application
    Filed: June 5, 2015
    Publication date: September 24, 2015
    Inventors: Samuel S. Murray, Elsa J. Brochmann-Murray, Keyvan Behnam, Jeffrey C. Wang
  • Publication number: 20150246158
    Abstract: A cyclized peptide designated BMP Binding Peptide (BBP) is a synthetic peptide that avidly binds rhBMP-2, as do endogenous forms of BBP, and sequence conservation between species results in a variety of useful BBP compositions. BBP increases the over-all osteogenic activity of rhBMP-2, increases the rate at which rhBMP-2 induces bone formation, and BBP induces calcification alone. Compositions and substrates including BBP, and methods of using BBP are useful in therapeutic, diagnostic and clinical applications requiring calcification and osteogenesis.
    Type: Application
    Filed: March 6, 2015
    Publication date: September 3, 2015
    Inventors: Samuel S. Murray, Elsa J. Murray, Jeffrey C. Wang, Keyvan Behnam
  • Patent number: 9050300
    Abstract: The present invention relates to the clinical application of BBP, alone or in combination with other growth factors, for use in bone healing applications, such as spinal surgery. Additional applications include use in orthopedic implantable prostheses and implantation into other surgical sites (e.g., surgical reconstruction, regional osteopenia, etc.) where bone is desired.
    Type: Grant
    Filed: April 5, 2013
    Date of Patent: June 9, 2015
    Assignees: The Regents of The University of California, The United States of America Represented by The Department of Veterans Affairs
    Inventors: Samuel S. Murray, Elsa J. Brochmann-Murray, Keyvan Behnam, Jeffrey C. Wang
  • Patent number: 8962569
    Abstract: Provided herein is tumor suppression composition and methods of making and using the same.
    Type: Grant
    Filed: May 25, 2011
    Date of Patent: February 24, 2015
    Assignees: The Regeants of the University of California, The United States of America as Represented by the Department of Veterans Affairs
    Inventors: Samuel S. Murray, Elsa J. Murray, Jeffrey C. Wang
  • Publication number: 20140178346
    Abstract: Cell compositions for tissue engineering are provided which contain a population of autologous, minimally passaged dermal fibroblasts in combination with a tissue engineering matrix or scaffold, or material forming a matrix or scaffold. In one embodiment, the population of fibroblasts is genetically engineered to secrete a therapeutic protein in an amount effective to induce tissue growth or tissue repair when the cell composition is transplanted into a subject in need thereof. For example, the therapeutic protein can be a bone morphogenic protein when the tissue to be treated is bone tissue. A preferred bone morphogenic protein is BMP-2.
    Type: Application
    Filed: December 24, 2013
    Publication date: June 26, 2014
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: James A. Byrne, Jeffrey C. Wang
  • Publication number: 20140135845
    Abstract: Laminoplasty plates are engageable to at least one portion of a divided lamina to maintain a desired spacing relative to the spinal canal. The laminoplasty plates include a spacer portion having a first end and a second end that spans a gap formed by at least one of a divided lamina portion. The laminoplasty plates can include a lamina engagement portion at one end for engagement with the divided lamina portion.
    Type: Application
    Filed: January 24, 2014
    Publication date: May 15, 2014
    Applicant: WARSAW ORTHOPEDIC, INC.
    Inventors: William B. Null, Robert W. Weakley, Gregory C. Marik, John G. Heller, Jeffrey C. Wang
  • Publication number: 20130303449
    Abstract: The present invention relates to the clinical application of BBP, alone or in combination with other growth factors, for use in bone healing applications, such as spinal surgery. Additional applications include use in orthopedic implantable prostheses and implantation into other surgical sites (e.g., surgical reconstruction, regional osteopenia, etc.) where bone is desired.
    Type: Application
    Filed: April 5, 2013
    Publication date: November 14, 2013
    Inventors: Samuel S. MURRAY, Elsa J. BROCHMANN-MURRAY, Keyvan BEHNAM, Jeffrey C. WANG
  • Publication number: 20130143811
    Abstract: Provided herein is tumor suppression composition and methods of making and using the same.
    Type: Application
    Filed: May 25, 2011
    Publication date: June 6, 2013
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Samuel S. Murray, Elsa J. Murray, Jeffrey C. Wang
  • Patent number: 8415302
    Abstract: The present invention relates to the clinical application of BBP, alone or in combination with other growth factors, for use in bone healing applications, such as spinal surgery. Additional applications include use in orthopedic implantable prostheses and implantation into other surgical sites (e.g., surgical reconstruction, regional osteopenia, etc.) where bone is desired.
    Type: Grant
    Filed: December 26, 2007
    Date of Patent: April 9, 2013
    Assignees: The Regents of the University of California, The United States of America as Represented by the Department of Veterans Affairs
    Inventors: Samuel S. Murray, Elsa J. Brochmann-Murray, Keyvan Behnam, Jeffrey C. Wang
  • Patent number: 8193312
    Abstract: A cyclized peptide designated BMP Binding Peptide (BBP) is a synthetic peptide that avidly binds rhBMP-2, as do endogenous forms of BBP, and sequence conservation between species results in a variety of useful BBP compositions. BBP increases the over-all osteogenic activity of rhBMP-2, increases the rate at which rhBMP-2 induces bone formation, and BBP induces calcification alone. Compositions and substrates including BBP, and methods of using BBP are useful in therapeutic, diagnostic and clinical applications requiring calcification and osteogenesis.
    Type: Grant
    Filed: November 16, 2007
    Date of Patent: June 5, 2012
    Assignees: The Regents of the University of California, The United States of America as represented by the Department of Veterans Affairs
    Inventors: Samuel S. Murray, Elsa J. Murray, Jeffrey C. Wang, Keyvan Behnam
  • Patent number: 8182518
    Abstract: A cervical bone plate includes a graft window that allows access to and/or visualization of a bone graft area of the cervical spine after attachment of the present cervical plate to the vertebrae. The window is preferably, but not necessarily, sized for maximum exposure of the graft area and/or the vertebral body without compromising plate strength, particularly with respect to federal standards for such devices. The window is centrally positioned on the plate and is sized to provide alignment of the plate onto the vertebrae at the base of the vertebra fastener or screw holes of the plate. In a dynamic form of this cervical bone plate, the graft window expands and contracts with respective expansion and contraction of the dynamic plate after attachment to the vertebrae (i.e. “dynamizes”). In another form, a three-component dynamic bone plate is configured such that a middle component accepts an identical end component at both ends of the middle component. The end component is a 180° interchangeable part.
    Type: Grant
    Filed: December 21, 2004
    Date of Patent: May 22, 2012
    Assignee: Life Spine, Inc.
    Inventors: Michael S. Butler, Jeffrey C. Wang
  • Patent number: 8105366
    Abstract: Laminoplasty plates are engageable to at least one portion of a divided lamina to maintain a desired spacing relative to the spinal canal. The laminoplasty plates include a spacer portion having a first end and a second end that spans a gap formed by at least one of a divided lamina portion. The laminoplasty plates can include a lamina engagement portion at one end for engagement with the divided lamina portion.
    Type: Grant
    Filed: May 28, 2003
    Date of Patent: January 31, 2012
    Assignee: Warsaw Orthopedic, Inc.
    Inventors: William B. Null, Robert W. Weakley, Gregory C. Marik, John G. Heller, Jeffrey C. Wang
  • Patent number: 8043212
    Abstract: A method for providing treatment at or near a cervical region of the spine of a patient is provided. An incision is formed in the skin of a patient above the cervical region. An elongate body is inserted into the patient through the incision, the elongate body having a distal portion, a proximal portion, an outer surface, and an inner surface, the inner surface defining a passage extending through the elongate body. The elongate body is advanced until a distal end thereof resides at or near the cervical region of the spine. The size of the passage in the distal portion is increased relative to the size of the proximal portion.
    Type: Grant
    Filed: September 27, 2005
    Date of Patent: October 25, 2011
    Assignee: Zimmer Spine, Inc.
    Inventors: Hyun W. Bae, Robert F. Heary, Alan S. Hilibrand, Ashwini D. Sharan, Jeffrey C. Wang, Gene P. DiPoto, John D. Unger
  • Patent number: 7959677
    Abstract: Insertion methods for placing dynamic interbody devices between a first vertebra and a second vertebra using a posterior approach are provided. In an embodiment, the insertion method may be based on the first vertebra. A bridge assembly may be attached to tap shafts positioned in the first vertebra. The bridge assembly may establish an insertion angle of implants into a disc space between the vertebrae. In an embodiment, the insertion method may be based on the position of expandable trials positioned between the vertebrae. The trials may be positioned and a bridge assembly may be coupled to the expandable trials and taps positioned in the first vertebra. One or more posterior stabilization systems may be coupled to the vertebrae after insertion of the dynamic interbody devices between the vertebrae.
    Type: Grant
    Filed: January 19, 2007
    Date of Patent: June 14, 2011
    Assignee: Flexuspine, Inc.
    Inventors: Michael E. Landry, Erik J. Wagner, Michael S. Schular, Jeffrey C. Wang